First Patient in Florida Treated in Tampa in the OASIS Clinical Trial of the RENOVA iStim System for Overactive Bladder TAMPA, Fla., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Overactive bladder or OAB, affects millions of women of all ages, and can negatively impact nearly every aspect of daily life—from work performance to...

First U.S. Patient Treated in OASIS Clinical Trial of RENOVA iStim System for Overactive Bladder PARK CITY, Utah and OMAHA, Neb., Oct. 08, 2020 (GLOBE NEWSWIRE) -- BlueWind Medical announced today that clinical investigators in the OverActive Bladder Stimulation System Study (OASIS) of the...

BlueWind Initiates U.S. Enrollment in Clinical Trial of the RENOVA iStim to Treat Overactive Bladder PARK CITY, Utah and HERZLIYA, Israel, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BlueWind Medical announced today that enrollment has commenced at U.S. sites in the Pivotal Clinical Trial of the RENOVA...